Stock Comparison
MDGL vs VRTX
Madrigal Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.82B
$124.70B
P/E (TTM)
—
29.2
Forward P/E
666.7
25.8
Price/Sales
10.4
10.2
Price/Book
21.8
6.4
EV/EBITDA
-8.3
24.0
Dividend Yield
—
—
Profitability
Net Margin
-27.30%
35.50%
Operating Margin
-29.80%
38.10%
Return on Equity
-49.30%
24.20%
Return on Assets
-17.60%
12.10%
Growth (YoY)
Revenue Growth
126.80%
7.80%
Earnings Growth
0.00%
61.40%
Price & Risk
Beta
-1.1
0.3
52-Week High
$615.00
$507.92
52-Week Low
$284.02
$362.50
Analyst Target
$678.71
$548.69
Compare MDGL and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.